Novo Nordisk A/S

NYSE: NVO
$124.51
-$0.89 (-0.7%)
Closing price April 12, 2024
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.
Building on a turn toward more equity investments in the second quarter of this year, the top 50 hedge funds boosted their equity positions by nearly 3% in the third quarter.
November 7, 2016: Here are four stocks trading with relatively heavy volume among 106 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by nearly 5 to 1...
October 7, 2016: Here are four stocks trading with relatively heavy volume among 26 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by about 2.5 to 1...
September 27, 2016: Here are four stocks trading with relatively heavy volume among 43 equities making new 52-week lows in Tuesday’s session. NYSE advancers led decliners by nearly 3 to 2 and...
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
The top analyst upgrades, downgrades and initiations seen on Friday morning include Chesapeake Energy, JPMorgan, Melco Crown Entertainment, Navistar, Randgold Resources, Silver Wheaton, Verifone.
The top analyst upgrades, downgrades and initiations seen on Friday morning include Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva Pharmaceutical and Verifone.
At this point, bad news is coming in consistently to the point that any significant piece of good news could catapult Sanofi stock higher, making it an interesting choice for dip-buyers.
The top analyst upgrades, downgrades and initiations seen on Monday morning include BlackRock, Bristol-Myers, Level 3, NVIDIA, Monsanto and Twenty-First Century Fox.
Janus Capital has now launched the Obesity ETF, which has a strategy of investing in companies that provide treatment and care for obesity and obesity‐related disease.
The top analyst upgrades, downgrades and initiations seen on Monday, February 8 include Athenahealth, Baker Hughes, Cisco, LinkedIn, Orbital-ATK and Tableau Software.
Tuesday's top analyst upgrades, downgrades and initiations include AMD, Apple, Dollar General, Noble Energy and Oracle.
Thursday's top analyst upgrades, downgrades and initiations include Alcatel-Lucent, Apple, Coach, Etsy, Intel, MannKind, Netflix, SanDisk and Starbucks.
We ran a screen searching for Bank of America Merrill Lynch Buy-rated Japanese and European-listed American depositary shares that have at least 20% of sales in North America.
Source: ThinkstockInvestors have become increasingly anxious about how badly the U.S. equity and fixed income markets will be battered as the American government marches toward a potential default....